Legionellosis Cell Models for Research

Legionellosis, caused by Legionella species (primarily Legionella pneumophila), encompasses Legionnaires' disease (a severe pneumonia) and Pontiac fever (a mild febrile illness). According to WHO, the global burden is underestimated due to underdiagnosis, but reported incidence has increased in many countries. In the United States, the CDC reports approximately 10,000 cases annually, with a case fatality rate of 10-25% for Legionnaires' disease. Risk factors include advanced age, smoking, chronic lung disease, immunosuppression, and exposure to contaminated aerosolized water sources (e.g., cooling towers, hot tubs, decorative fountains). The 5-year survival for Legionnaires' disease is not typically reported as it is an acute infection; however, mortality can exceed 50% in immunocompromised patients or those with severe pneumonia. NCI does not provide cancer-specific survival for Legionellosis as it is not a malignant disease.

Legionellosis serves as a paradigm for studying intracellular bacterial pathogenesis, host-pathogen interactions, and innate immunity. The disease is ideal for mechanistic studies because:

• • Legionella pneumophila has a well-characterized type IV secretion system (Dot/Icm) that translocates effector proteins into host cells.
• • The host response involves multiple innate immune pathways, including inflammasome activation, autophagy, and cytokine signaling.
• • Public datasets (e.g., GEO, ArrayExpress) provide transcriptomic and proteomic data from infected cells and animal models.
• • Open questions include the molecular basis of host susceptibility, mechanisms of bacterial evasion, and the development of effective vaccines or host-directed therapies.

Subtypes: Legionella pneumophila serogroup 1 is the most common cause of Legionnaires' disease, but other serogroups and species (e.g., L. longbeachae) also cause disease. Research models often use L. pneumophila strains such as Philadelphia-1, Corby, and Paris.

Legionellosis is not a carcinogenic disease; however, the molecular pathogenesis involves several key host pathways that are hijacked or activated by Legionella. These pathways are not carcinogenic but are critical for infection and immune evasion.

1. Innate Immune Sensing Pathways:

• • Cytosolic sensing of bacterial flagellin by NAIP5/NLRC4 inflammasome.
• • Activation of caspase-1 and pyroptosis.
• • Type I interferon signaling via STING and TBK1/IRF3.

2. Autophagy and Vesicular Trafficking:

• • Legionella-containing vacuole (LCV) maturation and evasion of lysosomal fusion.
• • Recruitment of ER-derived vesicles and modulation of Rab GTPases.

3. NF-kB and MAPK Signaling:

• • Activation of pro-inflammatory cytokines (IL-6, TNF-alpha).
• • Modulation of apoptosis and cell survival.

4. Protein Translation and Stress Responses:

• • Inhibition of host protein synthesis by Legionella effectors.
• • Activation of the unfolded protein response (UPR).

Legionellosis is an infectious disease, and genetic alterations refer to host polymorphisms that influence susceptibility or bacterial genetic variations. The table below summarizes key host genetic variants and bacterial factors, with data from ClinVar, NCBI Gene, and published studies.

Note: Frequencies are approximate and based on published genomic studies of Legionella pneumophila isolates and human population genetics. Data from NCBI Gene and ClinVar.

Legionella infection leads to deregulation of multiple host signaling networks. Key nodes include:

• • Inflammasome pathway:
• • NAIP5/NLRC4: senses bacterial flagellin.
• • Caspase-1: activation leads to IL-1beta/IL-18 maturation and pyroptosis.
• • AIM2: senses bacterial DNA.
• • Autophagy pathway:
• • ATG5, ATG7, LC3: involved in LCV maturation.
• • Rab1, Rab7: regulate vesicle trafficking.
• • NF-kB pathway:
• • IKK complex, IkBalpha: activated by TLRs and cytokines.
• • p65/RelA: translocates to nucleus, induces pro-inflammatory genes.
• • MAPK pathway:
• • p38, JNK, ERK: modulate cytokine production and apoptosis.
• • PI3K/AKT pathway:
• • AKT: promotes cell survival and inhibits apoptosis.
• • PTEN: negative regulator, often targeted by bacterial effectors.
• • Type I interferon pathway:
• • STING, TBK1, IRF3: induced by cytosolic DNA.
• • Interferon-stimulated genes (ISGs): restrict bacterial replication.

Several cell lines are commonly used to study Legionella infection, including macrophages, epithelial cells, and amoebae. Organoids derived from human lung or intestine are emerging as more physiologically relevant models.

Organoid advantages: Human lung organoids can recapitulate the alveolar architecture and immune cell interactions, providing a more relevant model for studying Legionella pathogenesis and testing therapeutics.

Animal models are essential for studying Legionellosis pathogenesis and evaluating vaccines and drugs.

• • Mouse models:
• • A/J mice: permissive to Legionella due to a NAIP5 mutation; develop severe pneumonia.
• • C57BL/6 mice: resistant to Legionella; require high doses or immunocompromise.
• • Knockout mice: e.g., Nlrc4-/-, Casp1-/-, Myd88-/- to study specific pathways.
• • Guinea pig models:
• • Highly susceptible to Legionella; mimic human disease.
• • Zebrafish models:
• • Used for real-time imaging of bacterial infection and innate immune response.
• • PDX models:
• • Not applicable as Legionellosis is not a cancer.
• • GEMM (Genetically Engineered Mouse Models):
• • Mice with humanized immune system components (e.g., HLA transgenic) for vaccine studies.
• • Induced models:
• • Intranasal or aerosol infection with Legionella pneumophila.
• • Immunosuppression (e.g., corticosteroids) to enhance susceptibility.

CRISPR-Cas9 gene editing has revolutionized the creation of isogenic cell lines to study Legionella-host interactions. These models enable precise knockout or knock-in of specific genes to dissect their roles in infection.

Examples:

• • NAIP5 knockout THP-1 cells: generated by CRISPR to study the role of NAIP5 in flagellin sensing and inflammasome activation.
• • NLRC4 knockout macrophages: to investigate the contribution of NLRC4 to pyroptosis and cytokine release.
• • Caspase-1 knockout A549 cells: to study non-canonical inflammasome pathways.
• • ATG5 knockout HeLa cells: to examine autophagy in Legionella replication.
• • Knock-in of human NAIP5 variants: to model genetic susceptibility.
• • Reporter cell lines: e.g., NF-kB luciferase reporter THP-1 cells for high-throughput screening.

Commercially available, sequence-verified gene-edited cell models can accelerate research by providing ready-to-use, validated tools. These models are engineered using CRISPR and other gene-editing technologies, ensuring consistent and reproducible results. They are particularly valuable for drug discovery, target validation, and functional genomics studies.

Gene-edited cell lines are powerful tools for functional genomics in Legionellosis research. By knocking out or knocking in specific genes, researchers can validate their roles in host defense and bacterial pathogenesis.

Examples:

• • CRISPR knockout of NAIP5 in THP-1 cells confirms its essential role in flagellin-induced inflammasome activation.
• • Knockout of ATG5 in HeLa cells demonstrates the importance of autophagy in restricting Legionella replication.
• • Knock-in of a constitutively active STING mutant in A549 cells reveals enhanced type I interferon responses.
• • Genome-wide CRISPR screens in macrophages identify novel host factors required for Legionella infection.

These studies provide mechanistic insights and identify potential therapeutic targets.

Isogenic cell pairs (wild-type vs. knockout) are ideal for drug screening to identify compounds that specifically target host pathways or bacterial factors. For example:

• • Screening for inhibitors of inflammasome activation using NAIP5 knockout and wild-type THP-1 cells.
• • Testing antibiotics or host-directed therapies in Legionella-infected macrophages with or without specific gene knockouts.
• • Modeling resistance: gene-edited cells can be used to study mutations that confer resistance to antibiotics or immune effectors.

High-throughput screening with reporter cell lines (e.g., NF-kB luciferase) enables rapid identification of modulators.

CRISPR synthetic lethality screens can identify genetic dependencies in the context of Legionella infection. For instance, knocking out genes involved in DNA repair or cell cycle checkpoints may reveal vulnerabilities that can serve as biomarkers or therapeutic targets.

• • Genome-wide CRISPR screens in Legionella-infected cells can identify host genes essential for bacterial survival.
• • Transcriptomic profiling of gene-edited cells can uncover biomarkers of susceptibility or resistance.
• • Validation of candidate biomarkers using isogenic cell lines ensures specificity.